CTI Biopharma | CTIC - Market Capitalization

Name: CTI Biopharma | CTIC - Market Capitalization
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/
Keywords: CTI,Biopharma,CTIC,Market,Capitalization,stock,equity,live,intraday,earnings,share,price,historical data,chart,calendar,dividend,yield,news

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Features Questions? Contact us Already a Member? Login

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us

Please Paste this Code in your Website

width

height

Preview

CTI Biopharma

CTI Biopharma reported $1.19B in Market Capitalization this June of 2023, considering the latest stock price and the number of outstanding shares.

	Market Capitalization		Date
Baxter International BAX:US	USD 20.5B	5.19B	Mar/2023
Bristol-Myers Squibb BMY:US	USD 145.78B	7.2B	Mar/2023
CTI Biopharma CTIC:US	USD 554M	209M	Mar/2023
Eli Lilly LLY:US	USD 327.06B	20.56B	Mar/2023
Geron GERN:US	USD 1.1B	181M	Mar/2023
Incyte Corp INCY:US	USD 16.11B	1.76B	Mar/2023
Mirati Therapeutics MRTX:US	USD 2.16B	449M	Mar/2023
Northwest Biotherapeutics NWBO:US	USD 671M	155M	Mar/2023
Novartis NOVN:VX	USD 190.76B	10.17B	Mar/2023
Novartis NVS:US	USD 208.53B	8.83B	Mar/2023
Plus Therapeutics, Inc. CYTX:US	USD 10M	1000K	Mar/2023
Seattle Genetics SGEN:US	USD 37.89B	14.02B	Mar/2023